Home/Filings/4/0001214659-23-001044
4//SEC Filing

Stelzer Laurie 4

Accession 0001214659-23-001044

CIK 0001576263other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:00 PM ET

Size

7.0 KB

Accession

0001214659-23-001044

Insider Transaction Report

Form 4
Period: 2023-01-20
Transactions
  • Award

    Common Stock

    2023-01-20+26,86484,662 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-20+45,45645,456 total
    Exercise: $45.66Exp: 2033-01-20Common Stock (45,456 underlying)
Footnotes (2)
  • [F1]This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date.
  • [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001644348

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:00 PM ET
Size
7.0 KB